Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208–243
- 1 October 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 593 (2) , 332-334
- https://doi.org/10.1016/0006-8993(92)91331-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonistsBehavioural Brain Research, 1990
- Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanismsJournal of Neuroscience, 1989
- The motor effects of bromocriptine ? a reviewPsychopharmacology, 1988
- D1 and D2 dopamine agonist synergism: separate sites of action?Trends in Pharmacological Sciences, 1987
- Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in ratsBrain Research, 1986
- Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393Psychopharmacology, 1986
- Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393Neuropharmacology, 1986
- Hypothesis: Bromocriptine lacks intrinsic dopamine receptor stimulating propertiesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Bromocriptine in ParkinsonismBMJ, 1974
- Tremor and Involuntary Movements in Monkeys: Effect of L-Dopa and of a Dopamine Receptor Stimulating AgentScience, 1973